Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Lubitz

Showing results (41-50 of 353) with videos related to

Pageof 36
Sort By:
Heart, Lung & Circulation|June 12, 2017
Genetics of Atrial Fibrillation: State of the Art in 2017Diane Fatkin, Celine F Santiago, Inken G Huttner, et al.
Cardiovascular Digital Health Journal|March 10, 2022
Point-of-care screening for atrial fibrillation: Where are we, and where do we go next?Jeffrey M Ashburner, Shaan Khurshid, Steven J Atlas, et al.
Texas Heart Institute Journal|January 20, 2017
A "Malignant" Arrhythmia: Cardiac Metastasis and Ventricular TachycardiaMuthiah Vaduganathan, Nilay K Patel, Steven A Lubitz, et al.
The American Journal of Cardiology|August 22, 2017
Factors Associated with Anticoagulation Delay Following New-Onset Atrial FibrillationShaan Khurshid, Lu-Chen Weng, Olivia L Hulme, et al.
The American Journal of Cardiology|July 12, 2017
Changes in Use of Anticoagulation in Patients With Atrial Fibrillation Within a Primary Care Network Associated With the Introduction of Direct Oral AnticoagulantsJeffrey M Ashburner, Daniel E Singer, Steven A Lubitz, et al.
The Annals of Thoracic Surgery|January 13, 2021
Non-Vitamin K Antagonist Oral Anticoagulant vs Warfarin for Post Cardiac Surgery Atrial FibrillationVictor Nauffal, Ludovic Trinquart, Asishana Osho, et al.
Journal of the American Heart Association|August 13, 2021
Comparative Effectiveness of Implantable Defibrillators for Asymptomatic Brugada Syndrome: A Decision-Analytic ModelShaan Khurshid, Wanyi Chen, Weeranun D Bode, et al.
Scientific Reports|January 29, 2021
Approximate conditional phenotype analysis based on genome wide association summary statisticsPeitao Wu, Biqi Wang, Steven A Lubitz, et al.
Pharmacogenomics|August 12, 2009
CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosingStuart A Scott, Malgorzata Jaremko, Steven A Lubitz, et al.
American Journal of Human Genetics|November 22, 2016
A Functional Variant Associated with Atrial Fibrillation Regulates PITX2c Expression through TFAP2aJiangchuan Ye, Nathan R Tucker, Lu-Chen Weng, et al.
Pageof 36

Showing results (41-50 of 353) with videos related to

Sort By:
Pageof 36
Heart, Lung & Circulation|June 12, 2017
Genetics of Atrial Fibrillation: State of the Art in 2017Diane Fatkin, Celine F Santiago, Inken G Huttner, et al.
Cardiovascular Digital Health Journal|March 10, 2022
Point-of-care screening for atrial fibrillation: Where are we, and where do we go next?Jeffrey M Ashburner, Shaan Khurshid, Steven J Atlas, et al.
Texas Heart Institute Journal|January 20, 2017
A "Malignant" Arrhythmia: Cardiac Metastasis and Ventricular TachycardiaMuthiah Vaduganathan, Nilay K Patel, Steven A Lubitz, et al.
The American Journal of Cardiology|August 22, 2017
Factors Associated with Anticoagulation Delay Following New-Onset Atrial FibrillationShaan Khurshid, Lu-Chen Weng, Olivia L Hulme, et al.
The American Journal of Cardiology|July 12, 2017
Changes in Use of Anticoagulation in Patients With Atrial Fibrillation Within a Primary Care Network Associated With the Introduction of Direct Oral AnticoagulantsJeffrey M Ashburner, Daniel E Singer, Steven A Lubitz, et al.
The Annals of Thoracic Surgery|January 13, 2021
Non-Vitamin K Antagonist Oral Anticoagulant vs Warfarin for Post Cardiac Surgery Atrial FibrillationVictor Nauffal, Ludovic Trinquart, Asishana Osho, et al.
Journal of the American Heart Association|August 13, 2021
Comparative Effectiveness of Implantable Defibrillators for Asymptomatic Brugada Syndrome: A Decision-Analytic ModelShaan Khurshid, Wanyi Chen, Weeranun D Bode, et al.
Scientific Reports|January 29, 2021
Approximate conditional phenotype analysis based on genome wide association summary statisticsPeitao Wu, Biqi Wang, Steven A Lubitz, et al.
Pharmacogenomics|August 12, 2009
CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosingStuart A Scott, Malgorzata Jaremko, Steven A Lubitz, et al.
American Journal of Human Genetics|November 22, 2016
A Functional Variant Associated with Atrial Fibrillation Regulates PITX2c Expression through TFAP2aJiangchuan Ye, Nathan R Tucker, Lu-Chen Weng, et al.
Pageof 36